Meta-Analysis of Effect of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Risk in Type 2 Diabetes Mellitus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Meta-Analysis of Effect of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Risk in Type 2 Diabetes Mellitus

Published:2012-09 Issue:6 Volume:110 Page:826-833
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Patil Harshal R.,Al Badarin Firas J.,Al Shami Hamza A.,Bhatti Salman K.,Lavie Carl J.,Bell David S.H.,O'Keefe James H.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes;Nathan;Diabetes Care,2009

2. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement;Moher;Lancet,1999

3. Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes;Williams-Herman;Diabetes Obes Metab,2010

4. Comparison between vildagliptin and metformin to sustain reductions in HbA(1c) over 1 year in drug-naïve patients with type 2 diabetes;Schweizer;Diabet Med,2007

5. Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24-week, double-blind, randomized trial;Schweizer;Diabetes Obes Metab,2009

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of dipeptidyl peptidase-4 inhibitors on cardiac structure and function using cardiac magnetic resonance: a meta-analysis of clinical studies;Frontiers in Endocrinology;2024-09-11

2. Efficacy and Safety of DPP-4 Inhibitors and Metformin Combinations in Type 2 Diabetes: A Systematic Literature Review and Network Meta-Analysis;Diabetes, Metabolic Syndrome and Obesity;2024-06

3. Commentary on cardiovascular safety of DPP4Is: Focus on Alogliptin;Indian Journal of Pharmacy and Pharmacology;2023-03-15

4. Recent Trials on the Cardioprotective Effects of New Generation Anti-diabetic and Lipid-Lowering Agents;Frontiers in Clinical Drug Research-Diabetes and Obesity: Volume 7;2023-03-14

5. Safety and cardiometabolic efficacy of novel antidiabetic drugs;Expert Opinion on Drug Safety;2023-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3